跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DULOXETINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
DULOXETINE
Authorized
STANDARD
DULOXETINE
laboratoire riva inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e03ca6433574a789
Company
laboratoire riva inc.
Type
Standard
Approval Details
Approval Id
e03ca6433574a789
Drug Approval Canada Name
DULOXETINE
Product Name
DULOXETINE
Status
Marketed
Status Date
2020-04-06
Original Market Date
2020-04-06
Din
02495090
Drug Class
Human
Dosage Form
Capsule (Delayed Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
28:16.04.16
Atc Original
N06AX21 DULOXETINE
Atc Name
n 06 ax 21
Aig Number
0152350002
Company Name
laboratoire riva inc.
Company Address
660 Boul. Industriel, Blainville, Quebec, Canada, J7C 3V4
Active Ingredients
DULOXETINE (DULOXETINE HYDROCHLORIDE)
60 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e03ca6433574a789
Type
Standard
Back to Health Canada Approvals